Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Maxnerva Technology ServicesHKSE:01037 +0.81%48 Cyclically Adjusted PS Ratio is 0.69 as of Sep. 05, 2026, which is 130% above its 10-year median of 0.30. GuruFocus rates HKSE:01037 with a GF Score™ of 48/100 and a GF Value™ of HK$0.29 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,579 Software companies, Maxnerva Technology Services ranks better than 73.08% on this metric.
The historical rank and industry rank for Maxnerva Technology Services's Cyclically Adjusted PS Ratio or its related term are showing as below:
HKSE:01037'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.12 Med: 0.3 Max: 1.09
Current: 0.7
During the past 13 years, Maxnerva Technology Services's highest Cyclically Adjusted PS Ratio was 1.09. The lowest was 0.12. And the median was 0.30.
HKSE:01037's Cyclically Adjusted PS Ratio is ranked better than 73.08% of 1579
companies
in the Software industry
Industry Median: 1.65
vs HKSE:01037: 0.70
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Maxnerva Technology Services's adjusted revenue per share data of for the fiscal year that ended in Dec25 was HK$1.113. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is HK$0.90 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Maxnerva Technology Services (HKSE:01037) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Maxnerva Technology Services Cyclically Adjusted PS Ratio Related Terms
Maxnerva Technology Services Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maxnerva Technology Services Cyclically Adjusted PS Ratio Chart
HKSE:01037 vs IBM, ACN, CTSH: Cyclically Adjusted PS Ratio Comparison
For the Information Technology Services subindustry, Maxnerva Technology Services's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maxnerva Technology Services Cyclically Adjusted PS Ratio vs Software Industry
For the Software industry and Technology sector, Maxnerva Technology Services's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Maxnerva Technology Services's Cyclically Adjusted PS Ratio falls into.
Maxnerva Technology Services Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.69 mean?
Maxnerva Technology Services (HKSE:01037) has a Cyclically Adjusted PS Ratio of 0.69 as of Sep. 05, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Maxnerva Technology Services and its competitors. This is 130% above median its historical median of 0.30. Over the past decade, Maxnerva Technology Services' Cyclically Adjusted PS Ratio has ranged from 0.12 to 1.09. According to the industry distribution chart, Maxnerva Technology Services ranks #425 out of 1579 companies in the Software industry, placing it in the top 26.9%.
Is Maxnerva Technology Services' Cyclically Adjusted PS Ratio too high?
Maxnerva Technology Services' current Cyclically Adjusted PS Ratio of 0.69 is 130% above median its 10-year median of 0.30. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 1.09. The Software industry median Cyclically Adjusted PS Ratio is 1.65. Maxnerva Technology Services' value of 0.69 is 58.2% below this industry median. Based on the distribution chart, Maxnerva Technology Services ranks #425 out of 1579 companies in the Software industry, which is above the industry midpoint. Overall, Maxnerva Technology Services has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Maxnerva Technology Services' Cyclically Adjusted PS Ratio compare to IBM and ACN?
According to the Software industry distribution chart, Maxnerva Technology Services ranks #425 out of 1579 companies for Cyclically Adjusted PS Ratio. This puts Maxnerva Technology Services in the upper half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.65. Maxnerva Technology Services' value of 0.69 is 58.2% below this benchmark. Historically, Maxnerva Technology Services' own Cyclically Adjusted PS Ratio has ranged from 0.12 to 1.09 over the past decade. While the company's 10-year median is 0.30 vs. the industry median of 1.65, Maxnerva Technology Services has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Software company?
The median Cyclically Adjusted PS Ratio among Software companies is 1.65, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maxnerva Technology Services's current Cyclically Adjusted PS Ratio of 0.69 is 58.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Maxnerva Technology Services and its competitors. For the Software industry, the median Cyclically Adjusted PS Ratio is 1.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maxnerva Technology Services's current Cyclically Adjusted PS Ratio is 0.69, which is 130% above median its own 10-year median of 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maxnerva Technology Services stock overvalued right now?
Based on GuruFocus' analysis, Maxnerva Technology Services (HKSE:01037) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.29, compared to a current price of HK$0.63 — trading 115.5% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.69, which is 130% above median its 10-year median of 0.30 and 58.2% below the Software industry median of 1.65. Maxnerva Technology Services' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Maxnerva Technology Services (HKSE:01037), the current Cyclically Adjusted PS Ratio is 0.69 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maxnerva Technology Services (HKSE:01037) Overvalued in 2026?
Based on GuruFocus' analysis, Maxnerva Technology Services stock appears to be overvalued.
The current stock price of HK$0.63 is trading 115.5% above its estimated GF Value™ of HK$0.29.
GuruFocus considers Maxnerva Technology Services to be Significantly Overvalued.
Key valuation signals for HKSE:01037:
Cyclically Adjusted PS Ratio: 0.69 (130% above median its 10-year median of 0.30)
GF Value™: HK$0.29 vs. price of HK$0.63 (115.5% above fair value)
Industry Position: 58.2% below the Software median (#425 of 1579)
No single metric tells the full story. See the HKSE:01037 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maxnerva Technology Services Ltd provides a range of smart manufacturing solutions and services to customers, including the implementation of a combination of software systems and automation equipment and robots into the production lines to lower costs and increase operational effectiveness and efficiency through smart processes; the implementation of facility monitor and control system for monitoring the efficiency of the usage of water, power, and gas at production plants; the implementation of facial recognition system for labor and security management of the entire industrial parks; and the provision of testing and inspection services for new and existing electronic products. Its segments are Digital Industry Business which derives the majority of revenue, and Digital Life Business.
48GF Score
Get the complete analysis for HKSE:01037
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01037 has been successfully added to your 
